Phase II multi-institutional clinical trial on a new mixed beam RT scheme of IMRT on pelvis combined with a carbon ion boost for high-risk prostate cancer patients.
Marvaso G, Jereczek-Fossa BA, Vischioni B, Ciardo D, Giandini T, Hasegawa A, Cattani F, Carrara M, Ciocca M, Bedini N, Villa S, Morlino S, Russo S, Zerini D, Colangione SP, Panaino CMV, Fodor C, Santoro L, Pignoli E, Valvo F, Valdagni R, De Cobelli O, Orecchia R.
Marvaso G, et al. Among authors: valvo f.
Tumori. 2017 May 12;103(3):314-318. doi: 10.5301/tj.5000587. Epub 2016 Dec 2.
Tumori. 2017.
PMID: 28009421
Clinical Trial.